CAD & Atherosclerosis
News
Hormone therapy ‘timing hypothesis’ gains ground in ELITE
Key clinical point: Hormone therapy cut atherosclerotic progression, compared with placebo, in women 6 or fewer years out from menopause start,...
News
CABG plus mitral repair put under spotlight
Key clinical point: CABG plus mitral repair did not significantly improve left ventricular remodeling at 1 year, and was associated with some...
News
Bioabsorbable-polymer coronary stent achieves noninferiority endpoint
Key clinical point: A drug-eluting coronary stent with a bioabsorbable polymer proved noninferior to a conventional drug-eluting stent with a...
News
Obesity can cut 19 years of health, 8 years of life
Key clinical point: Excess body weight at a young age lowers life expectancy and years of health more than that at older ages. Major finding:...
News
FDA clears noninvasive method of obtaining FFR measurements
Conference Coverage
Pushing LDL below 25 mg/dL with alirocumab safe ‘so far’
Key clinical point: LDL cholesterol levels below 25 mg/dL induced by a superpotent investigational lipid-lowering agent appear to be safe through...
Conference Coverage
Simple risk score predicts dementia risk in type 2 diabetes
Key clinical point: It’s now readily possible to predict the 10-year dementia risk for individuals with type 2 diabetes.
Conference Coverage
CT screening not useful in high-risk diabetes patients
Key clinical point: CCTA screening did not reduce the composite endpoint, compared with optimal guideline-directed diabetes care. Major finding:...
Conference Coverage
Evidence builds for risk-based antihypertension guidelines
Key clinical point: Many people with systolic blood pressures of 120-139 mm Hg have significant cardiovascular disease risk that often goes...
Conference Coverage
Aspirin fails to protect elderly at-risk patients from cardiac events
Key clinical point: Low-dose aspirin may not prevent adverse cardiovascular outcomes in patients with atherosclerotic risk factors. Major finding...